|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 9/0019 | (2013.01) | ||
| A61K 47/18 | (2017.01) | ||
| A61K 47/183 | (2013.01) | ||
| A61K 47/26 | (2013.01) | ||
| A61K 47/26 | (2006.01) | ||
| C07K 16/241 | (2013.01) | ||
| A61K 47/02 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| C07K2317/21 | (2013.01) | ||
| A61P 1/00 | (2006.01) | ||
| C07K2317/76 | (2013.01) | ||
| A61P 1/04 | (2006.01) | ||
| A61K 39/39591 | (2013.01) | ||
| C07K 16/24 | (2006.01) | ||
| A61P 1/00 | (2018.01) | ||
| A61P 7/00 | (2006.01) | ||
| A61P 1/04 | (2018.01) | ||
| A61P 17/06 | (2006.01) | ||
| A61P 17/06 | (2018.01) | ||
| A61P 19/00 | (2006.01) | ||
| A61P 19/00 | (2018.01) | ||
| A61P 19/02 | (2006.01) | ||
| A61P 19/02 | (2018.01) | ||
| A61P 19/08 | (2006.01) | ||
| A61P 19/08 | (2018.01) | ||
| A61P 27/14 | (2006.01) | ||
| A61P 27/14 | (2018.01) | ||
| A61P 37/06 | (2006.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 29/00 | (2006.01) | ||
| A61P 37/06 | (2018.01) | ||
| A61P 7/00 | (2018.01) | ||
| A61K 47/02 | (2013.01) |
| (11) | Patento numeris | 3659582 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19215036.5 |
| Europos patento paraiškos padavimo data | 2015-05-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-06-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-08-16 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 14169754 | 2014-05-23 | EP |
| (72) |
RINALDI, Gianluca , IT
FRATARCANGELI, Silvia , IT
DEL RIO, Alessandra , IT
|
| (73) |
Fresenius Kabi Deutschland GmbH ,
Else-Kröner-Strasse 1, 61352 Bad Homburg,
DE
|
| (54) | LIQUID PHARMACEUTICAL COMPOSITION OF ADALIMUMAB |
| LIQUID PHARMACEUTICAL COMPOSITION OF ADALIMUMAB |